Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2018/0133197 CRYSTALLINE FORMS OF 4-CYANO-N-(2-(4,4-DIMETHYLCYCLOHEX-1-EN-1-YL)-6-(2,2,6,6-TETRAMETHYLTETRA- ...
The present disclosure discusses crystalline forms of 4-cyano-N-[2-(4,4-dimethylcyclohex-1-yl)-6-(2,2,6,6-tetramethyltetrahydro- ...
2018/0133196 COMPOSITION AND METHOD FOR TREATMENT OF SYMPTOMS ASSOCIATED WITH VARIOUS SKIN CONDITIONS
Compositions containing imidazole-based compounds, and optionally, colloidal oatmeal, for the treatment, prevention, and management of symptoms, conditions,...
2018/0133195 COMPOSITIONS AND METHODS COMPRISING CELECOXIB OR RELATED COMPOUNDS AND DEXTROMETHORPHAN
Neurological disorders may be treated by administering a therapeutically effective amount of dextromethorphan and a therapeutically effective amount of a...
2018/0133194 METHOD OF TREATING INFLAMMATION USING NATURAL COMPOUNDS AND/OR DIET
The current invention is directed to a treatment of an inflammatory disease comprising administering to a subject in need of such treatment a composition...
2018/0133193 NOVEL USE OF GENINSTEIN
Use of genistein for the treatment and prevention of dry eye syndrome or LKC and corresponding compositions containing it.
2018/0133192 Fructose analogs and their combinations as anti-cancer agents
The present invention provides a fructose analogue and a composition thereof which can be used for cancer treatment, has a targeting effect and has little...
2018/0133191 METHOD OF TREATING CHRONIC KIDNEY DISEASE
The present invention discloses pharmaceutical-grade ferric organic compounds having enhanced dissolution rate. These ferric organic compounds, including but...
2018/0133190 MONOACYLGLYCEROLS AND FAT-SOLUBLE NUTRIENTS FOR USE IN THE TREATMENT OF NUTRIENT DEFICIENCY FROM MALDIGESTION
Compositions comprising monoacylglycerols (MAG), such as sn-1(3) MAG, and further comprising fat-soluble nutrients such as fat-soluble vitamins and ...
2018/0133189 FORMULATIONS AND USES OF RETINOIC ACID RECEPTOR SELECTIVE AGONISTS
The invention provides retinoic acid receptor (RAR) selective agonists and formulations thereof for the treatment of disease or for inducing a medically...
2018/0133188 WEIGHT-LOSS BEVERAGE COMPOSITION AND METHOD
A weight-loss beverage composition including L-carnitine-L-tartrate, green tea extract, green coffee bean extract/chlorogenic acid, at least one B vitamin,...
2018/0133187 CYP450 Lipid Metabolites Reduce Inflammation and Angiogenesis
Methods for reducing angiogenesis, inflammation, and vascular permeability in a subject by administering an epoxymetabolite of Docosahexaenoic acid (DHA) and...
2018/0133186 PREVENTATIVE TREATMENT OF ALZHEIMER'S DISEASE
The present disclosure provides methods and formulations for the treatment of Alzheimer's disease in a subject in need thereof. The methods comprise...
2018/0133185 Compositions and Methods for the Improvement of Memory
Compositions and methods are provided for the improvement of memory.
2018/0133184 METHOD FOR TREATING IDIOPATHIC PULMONARY FIBROSIS
Aspects of the disclosure relate to a method for treating idiopathic pulmonary fibrosis (IPF) in a patient with N-acetylcysteine (NAC) comprising administering...
2018/0133183 RECEPTOR SUBTYPE AND FUNCTION SELECTIVE RETINOID AND REXINOID COMPOUNDS IN COMBINATION WITH IMMUNE MODULATORS...
Disclosed herein are methods for treating cancer comprising administering at least one immune checkpoint inhibitor and at least one Retinoic Acid Receptor or...
2018/0133182 RECEPTOR SUBTYPE AND FUNCTION SELECTIVE RETINOID AND REXINOID COMPOUNDS IN COMBINATION WITH IMMUNE MODULATORS...
Disclosed herein are methods for treating cancer comprising administering at least one immune checkpoint inhibitor and at least one Retinoic Acid Receptor or...
2018/0133181 RECEPTOR SUBTYPE AND FUNCTION SELECTIVE RETINOID AND REXINOID COMPOUNDS IN COMBINATION WITH IMMUNE MODULATORS...
Disclosed herein are methods for treating cancer comprising administering at least one immune checkpoint inhibitor and at least one Retinoic Acid Receptor or...
2018/0133180 RECEPTOR SUBTYPE AND FUNCTION SELECTIVE RETINOID AND REXINOID COMPOUNDS IN COMBINATION WITH IMMUNE MODULATORS...
Disclosed herein are methods for treating cancer comprising administering at least one immune checkpoint inhibitor and at least one Retinoic Acid Receptor or...
2018/0133179 RECEPTOR SUBTYPE AND FUNCTION SELECTIVE RETINOID AND REXINOID COMPOUNDS IN COMBINATION WITH IMMUNE MODULATORS...
Disclosed herein are methods for treating cancer comprising administering at least one immune checkpoint inhibitor and at least one Retinoic Acid Receptor or...
2018/0133178 COMPOUNDED SOLUTIONS OF DICLOFENAC AND LIDOCAINE AND METHODS
A compounded topical solution may include approximately 85% to approximately 95% (v/v) diclofenac sodium topical solution, 1.5% (w/w), and approximately 5% to...
2018/0133177 Treatment of NASH with Gemcabene
Methods and formulations to reduce elevated levels of lipids and apolipoprotein B in subjects having type IIb hyperlipidemia. Methods for preventing, delaying...
2018/0133176 LYOPHILIZED MESNA COMPOSITIONS
A sterile lyophilizate composition having improved stability and shelf-life. The lyophilizate includes from 30 to 100% of Mesna and 0 to 70% of an excipient. A...
2018/0133175 QUINONE COMPOUNDS FOR TREATING APE1 MEDIATED DISEASES
The invention described herein pertains to compounds and compositions for treating Ape1 mediated diseases. In particular, the invention described herein...
2018/0133174 Semisolid Aqueous Pharmaceutical Composition Containing Tapentadol
A semisolid aqueous pharmaceutical composition containing tapentadol or a physiologically acceptable salt thereof.
2018/0133173 FORMULATIONS FOR THE TREATMENT OF OCULAR SURFACE DISEASES AND RELATED METHODS
Formulations for treating ocular surface diseases, such as dry eye disease, and related methods are disclosed. The formulations include ambroxol or a chemical...
2018/0133172 MODIFIED-RELEASE THERAPEUTIC SYSTEMS FOR ORAL ADMINISTRATION OF CURCUMIN IN THE TREATMENT OF INTESTINAL DISORDERS
Disclosed are colon-specific delayed-release pharmaceutical compositions comprising: a) a matrix consisting of hydrophilic substances wherein curcumin is...
2018/0133171 COMPOSITION INCLUDING 3-BROMO-4,5-DIHYDROXYBENZALDEHYDE COMPOUND AS EFFECTIVE COMPONENT FOR PROTECTING AND...
There is provided a composition including a 3-bromo-4,5-dihydroxybenzaldehyde (BDB) for protecting human skin keratinocyte from ultraviolet, in which the BDB...
2018/0133170 METHODS AND COMPOSITIONS FOR TREATING DISORDERS
Compounds and compositions for treating disorders related to TRPA1 are described herein.
2018/0133169 PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING ARTHRITIS OR INFLAMMATORY DISEASE CONTAINING ...
Disclosed herein is a pharmaceutical composition for treating or preventing inflammatory diseases or arthritis, which includes ...
2018/0133168 PHARMACEUTICAL COMPOSITION FOR TREATING CANCER INCLUDING 2-METHOXY-4-(3-(4-METHOXYPHENYL)PROP-1-EN-1-YL)PHENOL...
The present disclosure relates to an anticancer use of a novel compound, i.e., 2-methoxy-4-(3-(4-methoxyphenyl)propyl-1-en-1-yl)phenol. The compound of the...
2018/0133167 IN VIVO SPERM SELECTION FOR TREATING MALE INFERTILITY
A composition and method are disclosed for optimizing sperm survival and function for couples suffering from male infertility by stimulating and increasing the...
2018/0133166 MODIFIED-RELEASE THERAPEUTIC SYSTEMS FOR ORAL ADMINISTRATION OF MENTHOL IN THE TREATMENT OF INTESTINAL DISORDERS
Disclosed are colon-specific delayed-release pharmaceutical compositions comprising: a) a matrix wherein micronised menthol with a particle-size distribution...
2018/0133165 Transdermal therapeutic system for the administration of peptides
The invention relates to a transdermal therapeutic system (TTS), which is suited for the administration of a peptide to a patient through skin treated with...
2018/0133164 FORMULATIONS AND KITS FOR FORMING BIOADHESIVE MATRICES
A bioadhesive formulation, comprising gelatin, alginate and a coupling agent, capable of forming a bioadhesive matrix, which is characterized by rapid curing,...
2018/0133163 METHODS FOR TARGETED IN VITRO AND IN VIVO DRUG DELIVERY TO MAMMALIAN CELLS VIA BACTERIALLY DERIVED INTACT MINICELLS
A composition comprising intact minicells that contain a drug molecule is useful for targeted drug delivery. One targeted drug delivery method employs...
2018/0133162 TUNABLE POLYMERIC COMPOSITE COATING FOR CONTROLLED RELEASE
A polymeric composite coating includes a drug release retardant polymer matrix, and pH-responsive nanoparticulate pore former. The pH-responsive pore formers...
2018/0133161 USE OF MAGNESIUM STEARATE IN DRY POWDER FORMULATIONS FOR INHALATION
Addition of magnesium stearate to a powder formulation for inhalation comprising carrier particles and an active ingredient bearing a group susceptible to...
2018/0133160 Alogliptin Formulation
The present invention belongs to the field of pharmaceutical industry and relates to a pharmaceutical composition comprising an intragranulate phase and an...
2018/0133159 METHODS AND MATERIALS FOR DELIVERING AGENTS TO LIVER TISSUE
This document provides methods and materials for delivering agents to liver tissue. For example, methods and materials for using microbeads to deliver agents...
2018/0133158 Formation of Particle Structures
Irregular, angular particles are produced by a manufacturing method that comprises forming a film on a substrate and then stretching the substrate along one or...
2018/0133157 METHODS AND COMPOSITIONS FOR TREATING PULMONARY HYPERTENSION
The present invention features methods for treating, stabilizing, preventing, and/or delaying pulmonary hypertension by administering nanoparticles that...
2018/0133156 METHOD FOR PRODUCING LIPOSOME AND APPARATUS FOR PRODUCING LIPOSOME
Disclosed herein are a method for producing a miniaturized liposome on a large production scale, and an apparatus for producing a liposome which is to be used...
2018/0133155 COMBINATION HIV THERAPEUTIC
Embodiments of the present invention are directed to particles having a Bryoid and a HDAC inhibitor for the treatment of latent viral disease.
2018/0133154 DECOY NUCLEIC ACID CATIONIC LIPOSOME CARRIER AND PREPARATION METHOD THEREOF
A preparation method of a Decoy nucleic acid cationic liposome carrier including: (1) mixing dioleoyl phosphoethanolamine and ...
2018/0133153 EYE DROP WITH DIFLUPREDNATE FOR MACULAR EDEMA TREATMENT
The present invention aims to provide an eye drop for treating macular edema. The present invention provides an eye drop for treating macular edema, which...
2018/0133152 MICROCHIP SUBSTANCE DELIVERY DEVICES HAVING LOW-POWER ELECTROMECHANICAL RELEASE MECHANISMS
Electromechanical substance delivery devices are provided which implement low-power electromechanical release mechanisms for controlled delivery of substances...
2018/0133151 NEBULIZED TIOTROPIUM
The present invention relates to therapeutic methods of administering tiotropium using a nebulizer. The present invention also relates to methods of treating...
2018/0133150 NASOLACRIMAL DRAINAGE SYSTEM IMPLANTS FOR DRUG THERAPY
An implant for insertion through a punctum and into a canalicular lumen of a patient. The implant includes a matrix of material, a therapeutic agent dispersed...
2018/0133149 DRUG-DELIVERING COMPOSITE STRUCTURES
Composite structures composed of a fibril core and a polymeric coat and designed capable of encapsulating both hydrophobic and hydrophilic bioactive agents...
2018/0133148 Degradable Microparticles for Protein and Small Molecule Delivery
The invention relates to a microparticle platform and pharmaceutical compositions capable of recruiting pro-regenerative cells to and/or reducing inflammation...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.